Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_provenance.
- NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_assertion description "[Despite the high incidence of revertant mosaicism (35%) in patients with the genetic skin disease epidermolysis bullosa (EB) due to correcting mutations in the genes COL17A1 and LAMB3, revertant mosaicism has not been described for COL7A1 until recently.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_provenance.
- NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_assertion evidence source_evidence_literature NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_provenance.
- NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_assertion SIO_000772 20574443 NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_provenance.
- NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_assertion wasDerivedFrom befree-2016 NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_provenance.
- NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_assertion wasGeneratedBy ECO_0000203 NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_provenance.
- befree-2016 importedOn "2016-02-19" NP821101.RAQtp1zzeVnfo3uVYrVB7MUadtEcG2KQM_YSq-dVMAFBw130_provenance.